Multi-drug resistant and extended spectrum beta-lactamase Gram-negative bacteria in bilateral lung transplant recipients. Incidence, risk factors and in-hospital mortality.
Annalisa Boscolo,Nicolò Sella,Tommaso Pettenuzzo,Alessandro De Cassai,Silvia Crociani,Chiara Schiavolin,Caterina Simoni,Federico Geraldini,Giulia Lorenzoni,Eleonora Faccioli,Francesco Fortarezza,Francesca Lunardi,Chiara Giraudo,Andrea Dell’Amore,Annamaria Cattelan,Fiorella Calabrese,Dario Gregori,Federico Rea,Paolo Navalesi
DOI: https://doi.org/10.1016/j.chest.2022.06.046
IF: 9.6
2022-07-16
Chest
Abstract:Background In the last few decades, the incidence of multidrug-resistant and extended spectrum beta-lactamase (MDR/ESBL) Gram-negative (GN) bacteria has progressively increased among lung transplant (LT) recipients. A prompt diagnosis, prevention and management of these pathogens remain the cornerstone for successful organ transplant. Research question What are the incidence of MDR/ESBL GN bacteria within the first 30 days following LT and related risk of in-hospital mortality? What are the potential clinical predictors of isolation of MDR/ESBL GN bacteria? Study design and Methods All consecutive LT patients admitted to the Intensive Care Unit of the University Hospital of Padua (February, 2016 - December, 2021) were retrospectively screened. Only adult patients undergoing the first bilateral LT, not requiring invasive mechanical ventilation and/or extracorporeal membrane oxygenation before surgery, were included. MDR/ESBL GN bacteria were identified using in vitro susceptibility tests and were isolated from the respiratory tract, blood, urine, rectal swab or surgical wound/drainage according to a routine protocol. Results 153 LT patients were screened and 132 were considered for analysis. Median age was 52 [IQR 41-60] years and 46 (35%) patients were females. MDR/ESBL GN bacteria were identified in 45 (34%) patients and 60% developed clinically relevant infection. Pseudomonas aeruginosa (n=22, 49%) and Klebsiella pneumoniae (n=17, 38%) were frequently isolated after LT (from the respiratory tract (n=21, 47%) and multi-sites (n=18, 40%)). Previous recipient-related colonization (HR 2.48 [1.04-5.90], P 0.04) and empirical exposure to broad-spectrum antibiotics (HR 6.94, CI [2.93-16.46], P < 0.01) were independent predictors of isolation of MDR/ESBL GN bacteria. In-hospital mortality of the MDR/ESBL group was 27% (HR 6.38, CI [1.98-20.63], P < 0.01). Interpretation The incidence of MDR/ESBL GN bacteria after LT was 34% and in-hospital mortality was six times greater. Previous recipient-related colonization and empirical exposure to broad-spectrum antibiotics were clinical predictors of isolation of MDR/ESBL GN bacteria.
respiratory system,critical care medicine